Virtus ETF Advisers LLC Intercept Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$9.99 - $18.71 $32,647 - $61,144	-3,268 Reduced 11.45%	25,272 $468,000
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $72,644 - $152,815	7,922 Added 38.42%	28,540 $315,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $4,598 - $7,967	367 Added 1.81%	20,618 $276,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $235,114 - $326,243	20,251 New	20,251 $250,000
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $305,406 - $417,688	-21,387 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $25,538 - $40,244	-1,966 Reduced 8.42%	21,387 $318,000
Q2 2021 Aug 10, 2021	BUY	$15.46 - $24.5 $61,499 - $97,461	3,978 Added 20.53%	23,353 $466,000
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $10,167 - $19,856	526 Added 2.79%	19,375 $447,000
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $271,116 - $470,355	11,075 Added 142.46%	18,849 $466,000
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $25,603 - $35,003	655 Added 9.2%	7,774 $322,000
Q2 2020 Aug 05, 2020	BUY	$46.7 - $92.04 $91,672 - $180,674	1,963 Added 38.07%	7,119 $341,000
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $21,032 - $51,625	-435 Reduced 7.78%	5,156 $325,000
Q4 2019 Feb 13, 2020	SELL	$57.36 - $124.1 $178,963 - $387,192	-3,120 Reduced 35.82%	5,591 $693,000
Q3 2019 Nov 12, 2019	SELL	$58.69 - $80.46 $86,215 - $118,195	-1,469 Reduced 14.43%	8,711 $578,000
Q2 2019 Aug 13, 2019	BUY	$77.77 - $120.68 $236,576 - $367,108	3,042 Added 42.62%	10,180 $810,000
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $144,907 - $190,433	1,578 Added 28.38%	7,138 $798,000
Q4 2018 Feb 05, 2019	SELL	$85.79 - $126.46 $348,135 - $513,174	-4,058 Reduced 42.19%	5,560 $560,000
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $57,341 - $82,652	648 Added 7.22%	9,618 $1.22 Million
Q2 2018 Aug 10, 2018	SELL	$60.0 - $85.67 $342,660 - $489,261	-5,711 Reduced 38.9%	8,970 $753,000
Q1 2018 May 14, 2018	SELL	$52.72 - $67.25 $45,391 - $57,902	-861 Reduced 5.54%	14,681 $903,000
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $409,786 - $512,303	7,041 Added 82.83%	15,542 $908,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,501	8,501 $1.03 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account